GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $3.01 $6.00 Friday, 19th Apr 2024 NEXI stock ended at $3.49. This is 5.76% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 14.38% from a day low at $3.06 to a day high of $3.50.
90 days $3.01 $28.69
52 weeks $0.150 $28.69

Historical NexImmune, Inc. prices

Date Open High Low Close Volume
2024-04-19 $3.13 $3.50 $3.06 $3.49 22 827
2024-04-18 $3.17 $3.34 $3.17 $3.30 6 911
2024-04-17 $3.42 $3.43 $3.01 $3.15 33 499
2024-04-16 $3.54 $3.62 $3.45 $3.47 8 959
2024-04-15 $3.71 $3.85 $3.42 $3.55 26 872
2024-04-12 $4.00 $4.00 $3.57 $3.61 21 974
2024-04-11 $3.80 $4.05 $3.80 $3.94 26 802
2024-04-10 $3.65 $4.10 $3.65 $3.96 83 813
2024-04-09 $4.03 $4.42 $3.62 $3.62 65 560
2024-04-08 $3.73 $4.35 $3.56 $4.30 190 755
2024-04-05 $4.58 $4.94 $3.69 $3.71 85 488
2024-04-04 $5.06 $5.09 $4.56 $4.58 19 335
2024-04-03 $5.36 $5.38 $5.03 $5.05 16 569
2024-04-02 $5.40 $5.59 $5.32 $5.36 13 598
2024-04-01 $5.57 $5.72 $5.50 $5.58 10 421
2024-03-28 $5.51 $5.70 $5.51 $5.61 12 193
2024-03-27 $5.75 $5.75 $5.51 $5.51 17 488
2024-03-26 $5.70 $5.80 $5.65 $5.69 18 243
2024-03-25 $5.74 $5.91 $5.63 $5.75 14 228
2024-03-22 $5.80 $5.85 $5.62 $5.64 16 555
2024-03-21 $5.71 $5.90 $5.70 $5.87 19 507
2024-03-20 $5.57 $6.00 $5.57 $5.72 33 588
2024-03-19 $5.60 $6.00 $5.54 $5.76 144 015
2024-03-18 $5.90 $6.08 $5.51 $5.60 75 789
2024-03-15 $6.10 $6.23 $5.79 $5.79 29 884
Click to get the best stock tips daily for free!

About NexImmune, Inc.

NexImmune. NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials f... NEXI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT